Inhibition of amino acid release by 5-HT1B receptor agonist in the rat prefrontal cortex

Polish Journal of Pharmacology

Volumn 54, Issue 6, 2002, Pages 625-631

  Gołembiowska, Krystyna ^a   Dziubina, Anna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

5 HT receptor agonists; Glutamate and aspartate release; Microdialysis; Rat prefrontal cortex

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ASPARTIC ACID; GLUTAMIC ACID; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [3 [3 (DIMETHYLAMINO)ETHOXY] 4 METHOXYPHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)(1,1' BIPHENYL) 4 CARBOXAMIDE; SB 216641; SEROTONIN 1B AGONIST; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; UNCLASSIFIED DRUG; VERATRIDINE;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; RAT; SCHIZOPHRENIA;

AMINO ACIDS; ANIMALS; MALE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS;

EID: 0036965774     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. 2A receptor-mediated modulation of GABA neurons in the rat prefrontal cortex. Soc. Neurosci. Abstr., 1998, 22, 514, abstr. 10.
2. Aghajanian G.K., Marek G.J.: Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology, 1997, 36, 589-599.
3. 2A, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res., 1999, 825, 161-171.
4. 2A,2C receptor agonist DOB on NMDA-evoked responses in the rat medial prefrontal cortex. Eur. J. Neurosci., 1999, 11, 2917-2934.
5. Bannon M.J., Roth R.H.: Pharmacology of mesocortical dopamine neurons. Pharmacol. Rev., 1983, 35, 53-68.
6. Barnes N.M., Sharp T.: A review of central 5-HT receptors and their function. Neuropharmacology, 1999, 38, 1083-1152.
7. 1B receptors. J. Pharmacol. Exp. Ther., 1989, 250, 37-43.
8. 1F receptor messenger RNA in rodent and primate brain. Neuropharmacology, 1994, 33, 367-386.
9. 1A antagonist. Brit. J. Pharmacol., 1995, 115, 1169-1174.
10. 2 receptors are enriched on neocortical pyramidal neurons destroyed by intrastriatal volkensin. J. Pharmacol. Exp. Ther., 1992, 261, 1273-1281.
11. Gerfen C.R.: The mesostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. Science, 1989, 246, 31-49.
12. Golembiowska K., Dziubina A.: Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex. Pol. J. Pharmacol., 2000, 52, 441-448.
13. Gołembiowska K., Dziubina A.: Glutamate and aspartate release from rat prefrontal cortex: evidence for modulation by serotonin receptor ligands. Pol. J. Pharmacol., 2001, 53, 129.
14. Gołembiowska K., Dziubina A.: Involvement of adenosine in the effect of antidepressants on glutamate and aspartate release in the rat prefrontal cortex. Naunyn-Schmied. Arch. Pharmacol., 2001, 363, 663-667.
15. Gołembiowska K., Zylewska A.: Effect of antidepressant drugs on veratridine-evoked glutamate and aspartate release in rat prefrontal cortex. Pol. J. Pharmacol., 1999, 51, 63-70.
16. (7) receptor in rat brain. Brit. J. Pharmacol., 1996, 117, 657-666.
17. 2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken. Mol. Brain Res., 1998, 54, 199-211.
18. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.: International Union of Pharmacology. Classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev., 1994, 46, 157-203.
19. Ichikawa J., Meltzer H.Y.: Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of atypical antipsychotic drugs. Eur. Arch. Psychiat. Clin. Neuros., 1999, 249, Suppl. 4. IV/90-IV/98.
20. 2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc. Nat. Acad. Sci. USA, 1998, 95, 735-740.
21. Kaneko T., Mizuno N.: Immunohistochemical study of glutaminase-containing neurons in the cerebral cortex and thalamus of the rat. J. Comp. Neurol., 1998, 267, 590-602.
22. Knecht R., Chang J.-Y.: Liquid chromatographic determination of amino acids after gas-phase hydrolysis and derivatization with (dimethylamino)azobenzenesulfonyl chloride. Anal. Chem., 1986, 58, 2375-2379.
23. 1B receptors of glutamatergic synaptic inputs onto serotonergic caudal raphe neurons in rat. J. Physiol., 1998, 510, 121-134.
24. 1-adrenoreceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur. J. Pharmacol., 1999, 367, 197-206.
25. Marek G.J., Wright R.A., Gewirtz J.C., Schoepp D.D.: A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience, 2001, 105, 379-392.
26. 1A receptors in guinea pig denate gyrus. Brain Res., 1996, 728, 175-180.
27. 1D receptors. Brit. J. Pharmacol., 1998, 123, 45-50.
28. McQuade R., Sharp T.: Functional mapping of dorsal and median raphe 5-hydroksytryptamine pathways in forebrain of the rat using microdialysis. J. Neurochem., 1997, 354, 147-150.
29. C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5HT, release in the frontal cortex in vivo. Neuropharmacology, 1998, 37, 953-955.
30. O'Hearn E., Molliver M.E.: Organization of raphecortical projections in rat: a quantitive retrograde study. Brain Res. Bull., 1984, 13, 709-726.
31. Paxinos G., Watson C.: The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, 1998.
32. 2C receptors. Mol. Brain Res., 1994, 23, 163-178.
33. 1D receptors. Naunyn-Schmied. Arch. Pharmacol., 1997, 356, 312-320.
34. 2C receptor. J. Pharmacol. Exp. Ther., 2001, 299, 83-89.
35. Read H.L., Beck S.G., Dun N.J.: Serotonergic suppression of interhemispheric cortical synaptic potentials. Brain Res., 1994, 643, 17-28.
36. Schmitz D., Gloveli T., Empson R.M., Draguhn A., Heinemann U.: Serotonin reduces synaptic excitation in the superficial medial entorhinal cortex of the rat via a presynaptic mechanism. J. Physiol., 1998, 508, 119-129.
37. 2A heteroceptors on thalamocortical glutamatergic neurons. J. Neurosci., 2000, 20, 8846-8852.
38. Seguela P., Watkins K.C., Geffard M., Descarries L.: Noradrenaline axon terminals in adult rat neocortex: an immunocytochemical analysis in serial thin sections. Neuroscience, 1990, 35, 249-264.
39. 2-activated interneuron. Brain Res., 1991, 506, 62-69.
40. 2C receptors. Pharmacol. Biochem. Behav., 1998, 61, 323-330.
41. 2A receptor agonists as antipsychotics. J. Pharmacol. Exp. Ther., 2001, 299, 268-279.
42. 2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse, 1997, 27, 79-82.
43. 7 receptor. Eur. J. Pharmacol., 2000,